Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)

In 2018, the World Health Organization (WHO) established the Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) to act as an advisory body to matters of global policies and strategies related to in vitro diagnostics (IVDs). The SAGE IVD is expected to meet annually to make recommendations on the content, format and implementation of the WHO model list of essential in vitro diagnostics (EDL) and on any matters related to IVDs.


Declarations of Interests

WHO Secretariat has received and assessed all the DOIs submitted by the participating experts. In accordance with WHO's policy, all declared interests, even if they do not give rise to a conflict of interest that would warrant partial or total exclusion of the expert concerned, will be disclosed within the Committee at the beginning of the meeting so that other members are aware of them. Many of the experts have extensive governmental experience and expertise – and consulting with WHO – in the areas that are the subject of the proceedings, which are considered relevant and important for the challenging tasks faced by the expert’s group.

Calls

SAGE IVD terms of reference

Document thumbnail

The document describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of March 2023. This version...

The document describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of December 2020. This...

thumbnail for the document

The following describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of June 2018. This version...

2021 SAGE IVD panel

Previous SAGE IVD panels

 

 

Publications

All →
Technical specifications for selection of essential in vitro diagnostics for SARS-CoV-2

NOTE: This publication is under review and a new version will be published during the third quarter of 2022. Technical specifications for in vitro diagnostics...

The selection and use of essential in vitro diagnostics - TRS 1031

Report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (including the third WHO model list of essential...

The selection and use of essential in vitro diagnostics: WHO technical report series;1022

The report of the second meeting of the Strategic Advisory Group of Experts on In Vitro was launched in November 2019 and includes the updated WHO Model...

Second WHO Model List of Essential In Vitro Diagnostics

This document is intended to provide a convenient reference to the second edition of the WHO Model List of Essential In Vitro diagnostics (EDL). The EDL...

First WHO model list of essential in vitro diagnostics

The three strategic priorities of WHO stated in its Thirteenth General Programme of Work 2019–2023 are to advance universal health coverage, address...